Antiviral Effect of a Combination Therapy of Amantadine/Biphenyl Dimethyl Dicarboxylate in HepG2 2.2.15 |
Joo, Seong-Soo
(College of Pharmacy, Chung-Ang University)
Won, Tae-Joon (College of Pharmacy, Chung-Ang University) Lee, Yong-Jin (College of Pharmacy, Chung-Ang University) Hwang, Kwang-Woo (College of Pharmacy, Chung-Ang University) Lee, Do-Ik (College of Pharmacy, Chung-Ang University) |
1 | Wright, M., Main, J. and Thomas, H. C. : Drug-resistant viral hepatitis. J. Infection. 41, 1 (2000) DOI ScienceOn |
2 | Witcher, J. W, Bouldinot, F. D., Baldwin, B. H., Ascenzi, M. A., Tennant, B. C., Du, J. F. and Chu, C. K : Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl) uracil in woodchucks. Antimicrob. Agents Chemother. 41, 2184 (1997) |
3 | Huber, R, Hockenjos, B. and Blum, H. E. : DDB treatment of patients with chronic hepatitis. Hepatology 39, 1732 (2004) DOI ScienceOn |
4 | Khabar, K. S. A., al-Haj, L., al-Zoghaibi, F., Marie, M., Dhalla, M., Polyak, S. J. and Williams, B. R. G. : Expressed gene cluster associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon. J. Mol. Biol. 342, 833 (2004) DOI ScienceOn |
5 | Joo, S. S., Won, T. J. and Lee, D. I. : Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res. 27, 954 (2004) DOI ScienceOn |
6 | Kang, K. W., Kim, Y. G., Kim, C. W. and Kim, S. G. : The antifibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) Arch. Pharm. Res. 25, 655 (2002). DOI ScienceOn |
7 | Bose, S., Kar, N., Maitra, R, DiDonato, J. A. and Banerjee, A. K. : Temporal activation of NF- regulates an interferonindependent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. USA 100, 10890 (2003) |
8 | Heathcote, E., Jeffers, L. and Wright, T. : Loss of serum HBV DNA and HBeAg seroconversion following short-term (12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase II studies. Hepatology 28, A620 (1998) DOI ScienceOn |
9 | Yamanaka, G., Wilson, T., Innaimo, S., Bisacchi, G. S., Egli, P., Rinehart, J. K, Zahler, R and Colonno, R. J. : Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus. Antimicrob. Agents Chemother. 43, 190 (1999) |
10 | Lee, W. M. : Hepatitis B virus infection. N. Engl. J. Med. 337, 1733 (1997) DOI ScienceOn |
11 | Kim, J. H., Mun, Y. J., Chun, H. J., Jeon, K. S., Kim, Y. O. and Woo, W. H. : Effect of biphenyl dimethyl dicarboxylate on the humoral immunosuppression by ethanol. Int. J. Immunother. 22, 906 (2000) |
12 | Lai, C. L., Ratziu, V., Yuen, M .-F. and Poynard, T. : Viral hepatitis B. Lancet 362, 2089 (2003) DOI ScienceOn |
13 | Biermer, M., Puro, R. and Schneider, R. J. : Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves distribution of capsid integrity through activation of NF-. J. Virol. 77, 4033 (2003) |
14 | Wang, C., Takeuchi, K, Pinto, L. and Lamb, R. A. : Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 67, 585 (1993) |
15 | Hoofnagle, J. H. : Hepatitis C: The clinical spectrum of disease. Hepatology 26, 15S (1997) DOI PUBMED ScienceOn |
16 | Oxford, J. S., Blasingam, B. S., Mann, A., Novelli, P. and Lambkin, R. : Treatment of epidemic and pandemic influenza with neuraminidase and M2 protein channel inhibitors. Clin. Midrobiol. Infect. 9, 1 (2003) DOI ScienceOn |
17 | Ramana, C. V., Gil, M. P., Schreiber; R. D. and Stark, G. R : STAT1-dependent and -independent pathways in IFN--dependent signaling. Trends Immunol. 23, 96 (2002) DOI ScienceOn |
18 | Guidotti, L. G., McClary, H., Loudis, J. M. and Chisari, F. V. : Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191, 1247 (2000) DOI ScienceOn |
19 | Fisher, K., Cheng, Y. and Tyrrell, D. : The mutation in duck hepatitis B polymerase which confers resistance to lamivudine (-L(-)-thiacytidine, 3TC) also confers cross-resistance to -L-dideoxy-5-fluorocytidine. Hepaiology 24, A246 (1996) |
20 | Tian, Z., Shen, X., Feng, H. and Gao, B. : IL-1 attenuates IFN--induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J. Immunol. 165, 3959 (2000) DOI |